Liver transaminasesBiomarker1 paperLatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01NephronResearch·15 SepSequential liraglutide and setmelanotide therapy in Bardet-Biedl Syndrome: metabolic and renal outcomes in a real-world case report and literature reviewLiraglutideENDO 2025 AbstractHuman trial·23 OctMON-206 The Efficacy of Fezolinetant for the Treatment of Vasomotor Symptoms due to Menopause in Individuals with and without Diabetes Mellitus: A Pooled Phase 3 AnalysisInterventionsENDO 2025 AbstractReview·23 OctSAT-662 GLP-1 And Advanced NASH: Impact On Liver Fibrosis RegressionInterventions
NephronResearch·15 SepSequential liraglutide and setmelanotide therapy in Bardet-Biedl Syndrome: metabolic and renal outcomes in a real-world case report and literature reviewLiraglutide
ENDO 2025 AbstractHuman trial·23 OctMON-206 The Efficacy of Fezolinetant for the Treatment of Vasomotor Symptoms due to Menopause in Individuals with and without Diabetes Mellitus: A Pooled Phase 3 AnalysisInterventions
ENDO 2025 AbstractReview·23 OctSAT-662 GLP-1 And Advanced NASH: Impact On Liver Fibrosis RegressionInterventions